Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03098823 · ClinicalTrials.gov registry record · Phase 4
A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE
A Phase 4 study, sponsored by Ampel BioSolutions.
- Completed
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
NCT03098823: Completed Phase 4 study, sponsored by Ampel BioSolutions.
NCT03098823 is a Phase 4 study that has completed, run by Ampel BioSolutions. The registered enrollment target is 62 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03098823, a Phase 4 study, has completed, sponsored by Ampel BioSolutions.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
Study Summary
To compare the effect of RAYOS® versus immediate-release (IR) prednisone on fatigue as measured by Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F).
Primary Outcome
Fatigue as measured in FACIT-F by patient
Interventions
- DRUG Prednisone
- DRUG RAYOS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2017-09-12 |
| Est. Completion | 2020-06-15 |
| Phase | Phase 4 |
What the finished NCT03098823 record still lists
NCT03098823 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Prednisone is the first listed.
NCT03098823 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03098823 about?
NCT03098823 is a clinical study titled "A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE". To compare the effect of RAYOS® versus immediate-release (IR) prednisone on fatigue as measured by Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F).
What is the current status of trial NCT03098823?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2017-09-12. Estimated completion is 2020-06-15.
What interventions are being tested in trial NCT03098823?
The interventions under investigation include: Prednisone (DRUG), RAYOS (DRUG).
Who is sponsoring clinical trial NCT03098823?
This trial is sponsored by Ampel BioSolutions, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03098823's enrollment target sits among peer trials
62 1110th of 2000 higher than 882 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI